HCA Healthcare, Inc. (HCA)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at HCA Healthcare, Inc..
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 2 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 402.60 $ — 25% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 12.6% above the current price.
- Consensus
- Sell
- Analyst Ratings
- 25
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 29.56 | 28.62 – 30.50 | 78,516 | 4.8% | 22 |
| 12/31/2027 | 32.16 | 30.30 – 34.04 | 81,634 | 8.8% | 22 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- 6.96 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 5.63 | -5.00 | 18,285 | 5.70 | 7.90 | 2,559 | 1,274 |
| 2025: Q1 | 6.45 | 8.70 | 18,321 | 5.70 | 8.80 | 1,651 | 660 |
| 2025: Q2 | 6.83 | 23.50 | 18,605 | 6.40 | 8.90 | 4,210 | 3,034 |
| 2025: Q3 | 6.78 | 38.70 | 19,161 | 9.60 | 8.60 | 4,416 | 3,128 |
| 2025: Q4 | 8.14 | 44.50 | 19,513 | 6.70 | 9.60 | 2,359 | 870 |
| 2026: Q1 | 7.15 | 10.70 | 19,109 | 4.30 | 8.50 | 2,014 | 895 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 41,490 | 6,198 | 2,890 | 7.30 | 5,653 | -5,633 | 33,758 |
| 2017 | 43,614 | 6,057 | 2,216 | 5.95 | 5,426 | -4,995 | 36,593 |
| 2018 | 46,677 | 6,642 | 3,787 | 10.66 | 6,761 | -2,918 | 39,207 |
| 2019 | 51,336 | 7,218 | 3,505 | 10.07 | 7,602 | -565 | 45,058 |
| 2020 | 51,533 | 7,262 | 3,754 | 10.87 | 9,232 | 2,892 | 47,490 |
| 2021 | 58,752 | 9,678 | 6,956 | 21.16 | 8,959 | 1,489 | 50,742 |
| 2022 | 60,233 | 9,053 | 5,643 | 19.15 | 8,522 | -73 | 52,438 |
| 2023 | 64,968 | 9,627 | 5,242 | 18.96 | 9,431 | 1,060 | 56,211 |
| 2024 | 70,603 | 10,547 | 5,760 | 22.00 | 10,514 | 555 | 59,513 |
| 2025 | 75,600 | 11,965 | 6,784 | 29.40 | 12,636 | -2,771 | 60,720 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
HCA Healthcare, Inc. bietet über ihre Tochtergesellschaften Gesundheitsdienste in den USA an.
| Employees | 230,000 |
|---|---|
| Headquarters | Nashville, TN |
| Address | One Park Plaza, 37203 Nashville, United States |
| Phone | 615 344 9551 |
| Website | hcahealthcare.com |
| IPO Date | 10. Mar 2011 |
| ISIN | US40412C1018 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Samuel N. Hazen | CEO & Director | 1960 |
| Michael A. Marks | CFO & Executive VP | 1970 |
| Jon Mack Foster | Executive VP & COO | 1962 |
| Michael R. McAlevey | Executive VP and Chief Legal & Administrative Officer | 1964 |
| Michael S. Cuffe M.B.A., M.D. | Executive VP & Chief Clinical Officer | 1966 |
| Thomas F. Frist Jr., M.D. | Founder & Chairman Emeritus | 1939 |
| Christopher F. Wyatt | Senior VP, Principal Accounting Officer & Controller | 1978 |
| Chad J. Wasserman | Senior VP & Chief Information Officer | – |
| Frank George Morgan C.F.A. | Vice President of Investor Relations | – |
| Wendy Warren | Senior VP and Chief Ethics & Compliance Officer | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.